{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:08:29Z","timestamp":1779430109631,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpsychires.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:54:34Z","timestamp":1772524474000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acceptability of suvorexant versus lemborexant: An inverse probability of treatment weighting analysis"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7016-5008","authenticated-orcid":false,"given":"Kota","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-878X","authenticated-orcid":false,"given":"Masakazu","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8830-0179","authenticated-orcid":false,"given":"Kenji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.03.002_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jagp.2018.10.017","article-title":"Trends in insomnia diagnosis and treatment among medicare beneficiaries, 2006\u20132013","volume":"27","author":"Albrecht","year":"2019","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2015.10.002","article-title":"Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis","volume":"30","author":"Anothaisintawee","year":"2016","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40268-018-0256-6","article-title":"Suvorexant (Belsomra\u00ae tablets 10, 15, and 20 mg): japanese drug-use results survey","volume":"19","author":"Asai","year":"2019","journal-title":"Drugs R&D"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav. Res."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.117.241422","article-title":"In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist","volume":"362","author":"Beuckmann","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"issue":"Suppl. ment","key":"10.1016\/j.jpsychires.2026.03.002_bib7","first-page":"S76","article-title":"Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy","volume":"26","author":"Dopheide","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1002\/pcn5.85","article-title":"Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment","volume":"2","author":"Hayashi","year":"2023","journal-title":"PCN Rep"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","article-title":"Insomnia as a predictor of mental disorders: a systematic review and meta-analysis","volume":"43","author":"Hertenstein","year":"2019","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chest.2017.01.026","article-title":"Insomnia and risk of cardiovascular disease","volume":"152","author":"Javaheri","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1070522","article-title":"Dual orexin receptor antagonists for treatment of insomnia: a systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant","volume":"13","author":"Khazaie","year":"2022","journal-title":"Front. Psychiatr."},{"issue":"1 15","key":"10.1016\/j.jpsychires.2026.03.002_bib13","first-page":"1","article-title":"Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis","volume":"15","author":"Kishi","year":"2025","journal-title":"Translational Psychiatry 2025"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11606-018-4390-1","article-title":"Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review","volume":"33","author":"Koffel","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3949\/ccjm.92a.24073","article-title":"Insomnia in older adults: a review of treatment options","volume":"92","author":"Le\u00f3n-Barriera","year":"2025","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5664\/jcsm.1472","article-title":"CBT for insomnia in patients with high and low depressive symptom severity: adherence and clinical outcomes","volume":"7","author":"Manber","year":"2011","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib17","article-title":"Short-term efficacy and safety of suvorexant and lemborexant: a retrospective study","volume":"16","author":"Mori","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/070674371105600905","article-title":"Prevalence of insomnia and its treatment in Canada","volume":"56","author":"Morin","year":"2011","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/17425255.2020.1817380","article-title":"Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders","volume":"16","author":"Muehlan","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jad.2023.11.082","article-title":"Analysis of sleep for the American population: result from NHANES database","volume":"347","author":"Nie","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/psyg.12858","article-title":"Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders","volume":"22","author":"Okino","year":"2022","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The european insomnia guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171051","article-title":"The present and future of synthetic orexin receptor agonists","volume":"167","author":"Saitoh","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1168100","article-title":"Treatment strategy for insomnia disorder: japanese expert consensus","volume":"14","author":"Takaesu","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.03.002_bib28","article-title":"Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists","volume":"2","author":"Usui","year":"2023","journal-title":"PCN Rep"},{"key":"10.1016\/j.jpsychires.2026.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.70089","article-title":"The prevalence of insomnia disorder in the general population: a meta-analysis","volume":"34","author":"van Straten","year":"2025","journal-title":"J. Sleep Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626001512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626001512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:43:36Z","timestamp":1779428616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626001512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S0022395626001512"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.03.002","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability of suvorexant versus lemborexant: An inverse probability of treatment weighting analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}